Effects of an adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in rats

Synapse

Volumn 49, Issue 4, 2003, Pages 279-286

  Nagel, Jens ^a   Schladebach, Henning ^a   Koch, Michael ^b   Schwienbacher, Isabel ^c   Müller, Christa E ^d   Hauber, Wolfgang ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Food intake; Locomotor activity; MSX 3; Rat; Sensorimotor gating

Indexed keywords

3 (3 HYDROXYPROPYL) 7 METHYL 8 (3 METHOXYSTYRYL) 1 PROPARGYLXANTHINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; MSX 2 COMPOUND; MSX 3 COMPOUND; XANTHINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPLORATORY BEHAVIOR; FEEDING; FEEDING BEHAVIOR; FOOD DEPRIVATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REWARD; SENSORIMOTOR FUNCTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; NERVE CELL INHIBITION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; FEEDING BEHAVIOR; LOCOMOTION; MALE; NEURAL INHIBITION; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; XANTHINES;

EID: 0042768094     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10240     Document Type: Article

References (49)

1. Bakshi, VP, Kelley AE. 1991. Dopaminergic regulation of feeding behavior. II. Differential effects of amphetamine microinfusions into three striatal subregions. Psychobiology 19:233-242
2. Barraco RA, Martens KA, Parizon M, Normile HJ. 1994. Role of adenosine A2a receptors in the nucleus accumbens. Prog Neuropsychopharm Biol Psychiatry 18:545-553.
3. Coupar IM, Tran BL. 2002. Effects of adenosine agonists on consumptive behavior and body temperature. J Pharm Pharmacol 54:289-294.
4. Daly JW, Fredholm BB. 1998. Caffeine - an atypical drug of dependence. Drug Alcohol Depend 51:199-206.
5. Essman WD, McGonigle P, Lucki I. 1993. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology 112:233-241.
6. Evans KR, Vaccarino FJ. 1986. Intra-nucleus accumbens amphetamine: dose-dependent effects on food intake. Pharmacol Biochem Behav 25:1149-1151.
7. Ferre S. 1997. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology 133:107-120.
8. Ferre S, Popoli P, Gimenez-Llort L, Rimondini R, Müller CE, Strömberg I, Ögren SO, Fuxe K. 2001. Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease. Parkinsonism Relat Disord 7:235-241.
9. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. 1994. Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
10. 2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 93:1349-1358.
11. Halldner L, Lozza G, Lindstrom K, Fredholm BB. 2000. Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist. Eur J Pharmacol 406:345-354.
12. 2a. receptors in the nucleus accumbens modulate prepulse inhibition of the startle response. Neuroreport 8:1515-1518.
13. 2A receptors in the nucleus accumbens and the caudate-putamen. Eur J Pharmacol 323:127-131.
14. 2A receptors in the caudate-putamen. Neuroreport 9:1803-1806.
15. 2A receptors in the caudate-putamen of rats. Eur J Neurosci 14:1287-1293.
16. Heimer L, Zahm DS, Churchill L, Kalivas PW, Wohltmann C. 1991. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41:89-125
17. Jacobson KA, Nikodijevic O, Padgett WL, Gallo-Rodriguez C, Maillard M, Daly JW. 1993. 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett 323:141-144.
18. Kelley AE. 1999. Neural integrative activities of nucleus accumbens subregions in relation to learning and motivation. Psychobiology 27:198-213.
19. Kelley AE, Delfs JM. 1994. Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 60:85-95.
20. Kinney GG, Wilkinson LO, Saywell KL, Tricklebank MD. 1999. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci 19:5644-5653.
21. Klarner A, Koch M, Schnitzler H-U. 1998. Induction of fos-protein in the forebrain and disruption of sensorimotoric gating following n-methyl-d-aspartate infusion into the ventral hippocampus of the rat. Neuroscience 84:443-452.
22. Koch M. 1999. The neurobiology of startle. Prog Neurobiol 59:107-128.
23. Koch M, Hauber W. 1998. Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat. Behav Pharmacol 9:23-29.
24. Kodsi MH, Swerdlow NR. 1997. Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat. Brain Res 773:45-52.
25. Maldonado-Irizarry CS, Kelley AE. 1995. Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat. Brain Res Bull 38:551-559.
26. 2A-selective adenosine receptor antagonists. Drug Dev Res 45:190-197.
27. Nagel J, Hauber W. 2002. Effects of salient environmental stimuli on extracellular adenosine levels in the rat nucleus accumbens measured by in vivo microdialysis. Behav Brain Res 134:485-492
28. Nehlig A, Daval J-L, Debry G. 1992. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17:139-170.
29. 2A receptors. Trends Pharmacol Sci 17:364-372.
30. Parkinson JA, Olmstead MC, Burns LH, Robbins TW, Everitt BJ. 1999. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci 19:2401-2411.
31. Pellegrino LJ, Pellegrino AS, Cushmann AJ. 1981. A stereotaxic atlas of the rat brain. New York: Plenum Press.
32. Phillips GD, Howes SR, Whitelaw RB, Robbins TW, Everitt BJ. 1995. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioral satiety sequence. Psychopharmacology (Berl) 117:82-90.
33. 2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats. Neurosci Lett 251:201-204
34. 2A receptor agonists on dopamine receptor agonist-induced behavioral responses in rats. Eur J Pharmacol 347:153-158.
35. Robbins TW, Everitt BJ. 1996. Neurobehavioral mechanisms of reward and motivation. Curr Opin Neurobiol 6:228-236.
36. 2A receptors in the rat central nervous system. J Comp Neurol 401:163-186.
37. 2A-selective adenosine receptor antagonists. J Med Chem 43:440-448.
38. Sills TL, Baird JP, Vaccarino FJ. 1993. Individual differences in the feeding effects of amphetamine: role of nucleus accumbens dopamine and circadian factors. Psychopharmacology 112:211-218.
39. Stratford TR, Kelley AE. 1997. GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J Neurosci 17:4434-4440.
40. Stratford TR, Kelley AE. 1999. Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 19:11040-11048.
41. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80:1171-1185.
42. 2A receptors underlies the behavioral activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79:753-764.
43. Swanson CJ, Heath S, Stratford TR, Kelley AE. 1997. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol Biochem Behav 58:933-945.
44. Swerdlow NR, Braff DL, Masten VL, Geyer MA. 1990a. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414-420.
45. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL. 1990b. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100:413-416.
46. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA. 2000. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20:4325-4336.
47. 2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens. Brain Res 707:75-80.
48. 2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and d-amphetamine-induced activity. Psychopharmacology 95:447-451.
49. Wan FJ, Swerdlow NR. 1993. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 113:103-109.